AGP Picks
View all

Technology Press Releases
Provided by AGP

Technology Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Press Releases.

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

Press releases published on September 1, 2026

Biometric Identity Security Provider BIO-key Participates at H.C. Wainwright Global Investment Conference Sept. 15th and 17th
Sep. 1, 2026

Biometric Identity Security Provider BIO-key Participates at H.C. Wainwright Global Investment Conference Sept. 15th and 17th

Indeterminate GlobeNewswire
Applied Biologics Activates First Clinical Site in Phase 3 BIOxHEAL™ Trial
Sep. 1, 2026

Applied Biologics Activates First Clinical Site in Phase 3 BIOxHEAL™ Trial

Indeterminate GlobeNewswire
3 E Network Secures $1.2 Million Enterprise DDR4 Memory Sales Order
Sep. 1, 2026

3 E Network Secures $1.2 Million Enterprise DDR4 Memory Sales Order

Indeterminate GlobeNewswire
Kala Bio and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program
Sep. 1, 2026

Kala Bio and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program

Indeterminate GlobeNewswire
ZenaTech to Showcase Drone as a Service Growth and ZenaDrone Defense Solutions at Series of U.S. and Global Investor and Defense Events
Sep. 1, 2026

ZenaTech to Showcase Drone as a Service Growth and ZenaDrone Defense Solutions at Series of U.S. and Global Investor and Defense Events

Indeterminate GlobeNewswire
Clearmind Reaches Key Milestone: CMND-100 Phase IIa now Underway for Alcohol Use Disorder Trial, One-Third of Part C Enrolled
Sep. 1, 2026

Clearmind Reaches Key Milestone: CMND-100 Phase IIa now Underway for Alcohol Use Disorder Trial, One-Third of Part C Enrolled

Indeterminate GlobeNewswire
FocalTherics™ to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Sep. 1, 2026

FocalTherics™ to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire
BridgeBio to Participate in September Investor Conferences
Sep. 1, 2026

BridgeBio to Participate in September Investor Conferences

Indeterminate GlobeNewswire
Pyxis Oncology to Participate in Upcoming Investor Conferences
Sep. 1, 2026

Pyxis Oncology to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Ardelyx to Participate in Upcoming Investor Conferences
Sep. 1, 2026

Ardelyx to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
F2G Announces Posters Accepted for Presentation at Upcoming Medical Meetings
Sep. 1, 2026

F2G Announces Posters Accepted for Presentation at Upcoming Medical Meetings

Indeterminate GlobeNewswire
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep. 1, 2026

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)
Sep. 1, 2026

Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)

Indeterminate GlobeNewswire
Alumis Announces Topline Results from Envudeucitinib Phase 2b Trial in Systemic Lupus Erythematosus (SLE)
Sep. 1, 2026

Alumis Announces Topline Results from Envudeucitinib Phase 2b Trial in Systemic Lupus Erythematosus (SLE)

Indeterminate GlobeNewswire
KANZHUN LIMITED Announces Change of Directors’ Executive Positions
Sep. 1, 2026

KANZHUN LIMITED Announces Change of Directors’ Executive Positions

Indeterminate GlobeNewswire
Telesat Government Solutions and Cailabs Collaborate on Secure Optical Connectivity for Government Missions
Sep. 1, 2026

Telesat Government Solutions and Cailabs Collaborate on Secure Optical Connectivity for Government Missions

Indeterminate GlobeNewswire
Arletta Pharma Solutions Appoints Jeannette Jager-van Dijk as Chief Executive Officer
Sep. 1, 2026

Arletta Pharma Solutions Appoints Jeannette Jager-van Dijk as Chief Executive Officer

Indeterminate GlobeNewswire
Kura Oncology to Participate in Three Investor Conferences in September
Sep. 1, 2026

Kura Oncology to Participate in Three Investor Conferences in September

Indeterminate GlobeNewswire
Descartes Acquires Extensiv
Sep. 1, 2026

Descartes Acquires Extensiv

Indeterminate GlobeNewswire
Ocugen Announces First Patient Dosed in Phase 3 Registrational Trial of OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
Sep. 1, 2026

Ocugen Announces First Patient Dosed in Phase 3 Registrational Trial of OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Technology Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.